Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of Compliance With Management of Acute Coronary Syndrome on Discharge From Cardiac Intensive Care

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patient admitted to the CIC unit for a first episode of acute coronary syndrome, in whom the CIC cardiologist considers that Crestor® -rosuvastatin is the most appropriate statin, in combination with a platelet aggregation inhibitor (Plavix®-clopidogrel)~* Patient giving his/her oral consent to participate in the study.~* Patient not previously treated by a lipid-lowering drug.~Exclusion Criteria:~* Patient with a known history of coronary heart disease.~* Patient whose treatment on discharge comprises only one of the two study treatments~* Patient participating or who has participated in the previous 3 months in a biomedical research study in cardiology.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).